Search clinical trials for: RECOMBIVAX HB™

Total 3775 results

Merck Sharp & Dohme LLC

Completed

Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)

Hepatitis B | Hepatocellular Carcinoma
University of Maryland, Baltimore

Completed

Hepatitis B Vaccine in Seniors

Hepatitis B Vaccination

United States
Merck Sharp & Dohme LLC

Completed

A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003)

Bacterial Infections; Virus Diseases
Merck Sharp & Dohme LLC

Completed

Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062)

Hepatitis B
Merck Sharp & Dohme LLC
MCM Vaccines B.V.

Completed

A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)

Virus Diseases | Bacterial Infections
Merck Sharp & Dohme LLC
MCM Vaccines B.V.

Completed

Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)

Virus Diseases | Bacterial Infections
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029) (PNEU-PED)

Pneumococcal Infections | Pneumococcal Vaccines

United States, Puerto Rico, Thailand, Turkey
Rockefeller University

Completed

Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers

Hepatitis B

United States
Merck Sharp & Dohme LLC

Completed

A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057)

Hepatitis B
Merck Sharp & Dohme LLC

Completed

Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults (V232-059)(COMPLETED)

Hepatitis B
GlaxoSmithKline

Completed

Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc

Hepatitis B | Hepatitis A

Germany, Belgium, Czechia
Sanofi Pasteur, a Sanofi Company

Completed

Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis

Hepatitis B | Pertussis | Tetanus | Diphtheria | Poliomyelitis

Canada
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse... and other collaborators

Completed

Effectiveness of Two Hepatitis B Vaccines in HIV-negative Youths

Hepatitis B

United States, Puerto Rico
GlaxoSmithKline
Aeras

Completed

Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants

Tuberculosis

Gambia
Johnson & Johnson Pte Ltd
Shanghai China-Norm Management Consulting co.,LTD; Shanghai Skin Disease Hospital

Completed

An 8-week Full Face HUT Clinical Trial for HydroBoost (2.0/3.0)

Adult Skin Healthy Signs

China
Hookipa Biotech GmbH

Recruiting

A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers

HPV-Related Squamous Cell Carcinoma

United States, Spain, Netherlands
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION)

Pneumococcal Infections

United States, Puerto Rico, Thailand, Turkey
Genexine, Inc.

Completed

Tolerability, Immunogenicity and Efficacy of HB-110 Administered by Electroporation in Chronic Hepatitis B Patients

Hepatitis B, Chronic

Korea, Republic of
Hookipa Biotech GmbH
Centre for Vaccinology Ghent - CEVAC

Completed

Trial to Evaluate Safety and Immunogenicity of a Vaccine Against HCMV

Cytomegalovirus Infection

Belgium
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Intermediate Size Expanded Access Protocol for the Treatment of Post-COVID-19 Syndrome

Post COVID-19 Syndrome

United States
Hope Biosciences
The University of Texas Health Science Center, Houston

Active, not recruiting

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy

Traumatic Brain Injury

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Intermediate Size Patient Population Expanded Access IND for the Treatment of Patients With Parkinson's Disease.

Parkinson Disease

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Individual Patient Expanded Access IND of Autologous HBadMSCs for the Treatment of Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

United States
Hope Biosciences Stem Cell Research Foundation

No longer available

Individual Patient Expanded Access IND to Treat Polyneuropathy

Polyneuropathies

United States
Hope Biosciences
The University of Texas Health Science Center, Houston

No longer available

Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Treatment of SCI

Spinal Cord Injury at C5-C7 Level

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

HBCMD01- Expanded Access for the Treatment of Congenital Muscular Dystrophy.

Congenital Muscular Dystrophy Due to Lamin A/C Mutation

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

Completed

A Clinical Trial to Determine the Safety and Efficacy of HB-adMSCs to Provide Protection Against COVID-19

COVID-19

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Individual Patient Expanded Access IND of HB-adMSCs for Chronic Musculoskeletal Pain.

Chronic Pain

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Individual Patient Expanded Access IND of Autologous HB-adMSCS for the Treatment of Bilateral Knee Pain.

Osteo Arthritis Knee | Knee Pain Chronic

United States
Hope Biosciences

Completed

Phase 1/2a Clinical Trial to Assess the Safety of HB-adMSCs for the Treatment of Rheumatoid Arthritis (HB-adMSCs)

Rheumatoid Arthritis

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

Withdrawn

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease

Alzheimer Disease

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for the Treatment of Cerebral Palsy

Cerebral Palsy

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Individual Patient Expanded Access IND of Autologous HB-adMSCs for the Treatment of Systemic Lupus Erythematosus (SLE)

System; Lupus Erythematosus

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Individual Patient Expanded Access IND for the Treatment of Stroke

Stroke | Stroke, Ischemic

United States
Hookipa Biotech GmbH

Recruiting

HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer Metastatic

United States
Sanofi Pasteur, a Sanofi Company

Completed

Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants

Hepatitis B | Pertussis | Diphtheria | Polio | Haemophilus Influenzae Type b

Thailand
Hookipa Biotech GmbH

Not yet recruiting

Safety, Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressive ART

Human Immunodeficiency Virus (HIV) Infection

United States
China Medical University Hospital
National Science and Technology Council; SEHA Kidney Care; Asia University Hospital

Recruiting

Hb Scope: A Multi-Center Validation Trial

Hemodialysis | Hemoglobin

Taiwan, United Arab Emirates
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

"Individual Patient Expanded Access IND to Treat Primary Lateral Sclerosis"

Primary Lateral Sclerosis, Adult, 1

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

An Expanded Access IND for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Chronic Inflammatory Demyelinating Polyneuropathy

United States
Memorial Sloan Kettering Cancer Center
Hookipa Biotech GmbH; Naveris

Recruiting

A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)

HPV16+ Squamous Cell Carcinoma

United States
Hookipa Biotech GmbH

Terminated

A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer

HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

Completed

A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs Against COVID-19.

COVID-19

United States
Shiraz University of Medical Sciences
Shahid Beheshti University of Medical Sciences

Completed

Effects a Honey Based Syrup on Blood Parameters in Patients With Breast Cancer

Breast Cancer

Iran, Islamic Republic of
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Influenzae Type b

Philippines
Honeybrains Biotech LLC
Cognitive Research Corporation

Completed

Safety and Efficacy of HB-1 for Panic Disorder

Panic Disorder

United States
Annecto LLC
Holy Redeemer Hospital

Terminated

Pilot Study Using Transcranial Electrostimulation (TESA-HB) Therapy for the Treatment of Depressive Symptoms (TESAHBPilot)

Mild to Moderate Depression

United States
Sanofi Pasteur, a Sanofi Company

Completed

Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Infections

Philippines
Sanofi Pasteur, a Sanofi Company

Completed

Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants

Hepatitis B | Pertussis | Tetanus | Diphtheria | Influenza

Philippines
Sangart

Completed

Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients

Shock, Hemorrhagic | Acidosis, Lactic | Shock, Traumatic

France, United Kingdom, South Africa, Germany

Search clinical trials for: RECOMBIVAX HB™

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations